Review of safety and efficacy of sleep medicines in older adults

JL Schroeck, J Ford, EL Conway, KE Kurtzhalts… - Clinical …, 2016 - Elsevier
Purpose Insomnia is problematic for older adults. After behavioral modifications fail to show
adequate response, pharmacologic options are used. The pharmacokinetics of agents used …

Personalized management approach for OSA

JC Carberry, J Amatoury, DJ Eckert - Chest, 2018 - Elsevier
OSA is a heterogeneous disorder. If left untreated, it has major health, safety, and economic
consequences. In addition to varying levels of impairment in pharyngeal anatomy …

《 中国成人失眠诊断与治疗指南》 解读

张鹏, 赵忠新 - 中国现代神经疾病杂志, 2013 - cqvip.com
为规范我国成人失眠的诊断与治疗, 中华医学会神经病学分会睡眠障碍学组邀请相关专家经多次
研讨, 最终形成《 中国成人失眠诊断与治疗指南》(《 指南》). 该《 指南》 既遵循循证医学原则 …

European guideline for the diagnosis and treatment of insomnia

D Riemann, C Baglioni, C Bassetti… - Journal of sleep …, 2017 - Wiley Online Library
This European guideline for the diagnosis and treatment of insomnia was developed by a
task force of the European Sleep Research Society, with the aim of providing clinical …

[PDF][PDF] S3-Leitlinie nicht erholsamer schlaf/schlafstörungen

D Riemann, E Baum, S Cohrs, T Crönlein… - …, 2017 - dgsm-archiv.not-only-pixel.de
4 Die Diagnostik soll eine umfassende Anamnese inklusive einer Abklärung körperlicher
und psychischer Erkrankungen, eine körperliche Untersuchung sowie den Einsatz von …

Clinical guideline for the evaluation and management of chronic insomnia in adults

S Schutte-Rodin, L Broch, D Buysse… - Journal of clinical …, 2008 - jcsm.aasm.org
Insomnia is the most prevalent sleep disorder in the general population, and is commonly
encountered in medical practices. Insomnia is defined as the subjective perception of …

Pharmacologic treatment of insomnia disorder: an evidence report for a clinical practice guideline by the American College of Physicians

TJ Wilt, R MacDonald, M Brasure, CM Olson… - Annals of internal …, 2016 - acpjournals.org
Background: Pharmacologic interventions are often prescribed for insomnia disorder.
Purpose: To assess the benefits, harms, and comparative effectiveness of pharmacologic …

Long-term efficacy and tolerability of lemborexant compared with placebo in adults with insomnia disorder: results from the phase 3 randomized clinical trial SUNRISE …

M Kärppä, J Yardley, K Pinner, G Filippov, G Zammit… - Sleep, 2020 - academic.oup.com
Abstract Study Objectives To assess long-term efficacy and safety of lemborexant (LEM), a
novel dual orexin receptor antagonist, versus placebo in adults with insomnia disorder …

[PDF][PDF] Insomnia: prevalence, consequences and effective treatment

D Cunnington, MF Junge, AT Fernando - Medical Journal of Australia, 2013 - mja.com.au
Identifying the body clock type of the patient is crucial in excluding circadian rhythm
disorders. A commonly undiagnosed condition, delayed sleep phase disorder is a body …

Assessing and managing sleep disturbance in patients with chronic pain

MD Cheatle, S Foster, A Pinkett… - …, 2016 - anesthesiology.theclinics.com
Patients with CP often present to clinicians with numerous medical and psychological
comorbidities, including mood and anxiety disorders, secondary medical problems related to …